Pharr Recognizes April 17th as Testicular Cancer Awareness Day

Translate to Spanish or other 102 languages!

The proclamation was presented to Mario Lizcano, Administrator of Corporate Affairs for DHR Health, and Claudia Chapa, Community Outreach Coordinator for DHR Health. Image courtesy of The City of Pharr
The proclamation was presented to Mario Lizcano, Administrator of Corporate Affairs for DHR Health, and Claudia Chapa, Community Outreach Coordinator for DHR Health. Image courtesy of The City of Pharr
- Advertisement -

The City of Pharr has declared April 17, 2025, as Testicular Cancer Awareness Day. Testicular cancer, the most common cancer among men aged 15-35, affects over 9,720 men annually, with approximately 600 cases resulting in death. This proclamation recognizes the courage of survivors, supports those currently fighting, and honors those who have lost their lives. It also underscores the crucial role of healthcare workers in improving detection and treatment options.

The proclamation was presented to Mario Lizcano, Administrator of Corporate Affairs for DHR Health, and Claudia Chapa, Community Outreach Coordinator for DHR Health. “We thank you for providing a platform for DHR Health to continue to provide education and community awareness and the opportunity to provide the screenings and testing that are available for all our community,” said Lizcano. 

On Testicular Cancer Awareness Day, the City of Pharr encourages men to consult with their doctors and calls on the community to increase awareness in the ongoing fight against this disease.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

DHR Health to Host Headache Symposium to Address Gap in Neurological Care, March 28th

In the United States, headaches remain a common health concern, affecting approximately one in six Americans. Migraines, a type of headache, are the second leading cause of years lived with disability nationwide.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
- Advertisement -